Edit |   |
---|---|
Antigenic Specificity | CD19 & CD3E, Human (Duvortuxizumab biosimilar) |
Clone | Duvortuxizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | scFv -h-CH2-CH3(_scFv)_h-CH2-CH3 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD19 & CD3E Recombinant Antibody (Duvortuxizumab). Duvortuxizumab (INN) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies. This drug was developed by Janssen Global Services. |
Immunogen | n/a |
Other Names | Anti-CD19 & CD3E Recombinant Antibody, Research Grade Duvortuxizumab, Anti-Human CD19 & CD3E Recombinant Antibody(Duvortuxizumab), JNJ-64052781, MGD011, RES192M1.2, Antibody Drug Analogues, Monoclonal Antibody, YR1422, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1831098-91-9 |
Catalog # | YR1422 |
Price | please inquire |
Order / More Info | CD19 & CD3E, Human (Duvortuxizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |